Lewes, DE -- (SBWIRE) -- 09/03/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Our Today’s Focus is on: BNP Paribas SA (ADR) (OTCMKTS:BNPQY), Axa SA (ADR) (OTCMKTS:AXAHY), Akamai Technologies, Inc. (NASDAQ:AKAM), Cellceutix Corp (OTCBB:CTIX)
BNP Paribas SA (ADR) (OTCMKTS:BNPQY) opened the session at $31.65, remained amid the day range of $31.31 - $31.76, and closed the session at $31.36. The stock showed a negative performance of -1.97% in previous trading session. The stock gained a volume of 49,538 shares and the average volume of the stock remained 90,751 shares. BNP Paribas SA provides a range of banking and financial services worldwide. Its retail banking business offers current accounts and other solutions in the areas of corporate financing and asset management; various banking, financial, and insurance products and services; personal loans, consumer credit, and mortgage financing; and equipment finance for corporate clients.
Has BNPQY Found The Bottom and Ready To Move Up? Find Out Here
Axa SA (ADR) (OTCMKTS:AXAHY) traded with volume of 46,218 shares in the prior session and the average volume of the stock remained 127,200 shares. The 52 week range of the stock remained $14.04 - $24.17. The stock showed a negative movement of -2.08% and closed its session at $21.69. The market capitalization of the stock remained 51.53 billion. AXA Group, through its subsidiaries, provides insurance and asset management services. Its Life & Savings segment offers term life, whole life, universal life, endowment, deferred and immediate annuities
Has YGE Found The Bottom And Ready To Gain Momentum? Find Out Here
Akamai Technologies, Inc. (NASDAQ:AKAM) closed yesterday at $45.98, a -1.12% decrease. Around 1.07 million shares were traded, low from an-average trading volume of 1.74 million shares. The company is now valued at around $8.19 billion. Akamai Technologies, Inc. provides content delivery and cloud infrastructure services for accelerating and improving the delivery of content and applications over the Internet in the United States and internationally.
Has AKAM Found The Bottom And Ready To Gain Momentum? Find Out Here
Cellceutix Corp (OTCBB:CTIX) volume of 174,283 shares, while the average volume remained 328,517 shares. The stock advanced +1.60% and finished the session Friday at $1.91. The EPS of the stock remained -0.04. The one month of the stock was -0.52% and three month trend remained negative -12.79%. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Why Should Investors Buy CTIX After The Recent Gain? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/